About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Casp8tm1Hed
targeted mutation 1, Stephen M Hedrick
MGI:3696985
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Casp8tm1Hed/Casp8tm1Hed
Cd19tm1(cre)Cgn/Cd19+
involves: 129P2/OlaHsd MGI:3697395
cn2
Casp8tm1Hed/Casp8tm1Hed
Tg(KRT14-cre)1Efu/0
Not Specified MGI:4888399


Genotype
MGI:3697395
cn1
Allelic
Composition
Casp8tm1Hed/Casp8tm1Hed
Cd19tm1(cre)Cgn/Cd19+
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casp8tm1Hed mutation (1 available); any Casp8 mutation (32 available)
Cd19tm1(cre)Cgn mutation (8 available); any Cd19 mutation (15 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• modest reduction in B1 cells (~10%) in peritoneal cavity is seen
• reduction in percentage of marginal zone B cells is observed
• spleen cell number is increased ~30% compared to wild-type
• in response to LPS and dsRNA, B cells have decreased proliferative response
• cells stimulated through Tlr9 or antigen receptor show similar proliferation and apoptosis to wild-type cells
• mice mount an inferior IgM response to LPS immunization

hematopoietic system
• in response to LPS and dsRNA, B cells have decreased proliferative response
• cells stimulated through Tlr9 or antigen receptor show similar proliferation and apoptosis to wild-type cells
• modest reduction in B1 cells (~10%) in peritoneal cavity is seen
• reduction in percentage of marginal zone B cells is observed
• spleen cell number is increased ~30% compared to wild-type
• mice mount an inferior IgM response to LPS immunization

cellular
• cells treated with LPS or dsRNA show decreased survival (increased apoptosis) compared to controls at 24 hours, with decreased viability starting at 12 hours
• cells stimulated through Tlr9 or antigen receptor show similar proliferation and apoptosis to wild-type cells
• in response to LPS and dsRNA, B cells have decreased proliferative response
• cells stimulated through Tlr9 or antigen receptor show similar proliferation and apoptosis to wild-type cells




Genotype
MGI:4888399
cn2
Allelic
Composition
Casp8tm1Hed/Casp8tm1Hed
Tg(KRT14-cre)1Efu/0
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casp8tm1Hed mutation (1 available); any Casp8 mutation (32 available)
Tg(KRT14-cre)1Efu mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• about 10% of mutants exhibit a mosaic skin phenotype and survive for months
• about 90% of mutants die by P15, while 10% survive for months

integument
• mutants exhibit an increase in epidermal water loss
• mutants develop atopic dermatitis-like skin disease
• about 90% of mutants exhibit a uniform skin phenotype and die by P15 while mutants that survive longer than P15, exhibit the skin phenotype on the posterior region of the back skin
• 2.5-fold increase in the numbers of blood vessels in the skin as indicated by marker analysis
• cutaneous edema is seen in the ears and feet
• affected skin of mutants surviving longer than P15 shows suprabasal cells with increased intracellular space, indicating development of spongiosis
• hyperproliferation of epithelial stem/progenitor cells in the skin
• the intracellular adhesion apparatus of the epidermis is disrupted, with keratinocytes showing an abnormal punctate localization of E-cadherin (Cdh1) due to increased shedding of E-cadherin
• mutants exhibit epidermal hyperplasia
• topical application of clobetasol, a corticosteroid, substantially reduces the epidermal hyperplasia and abolishes the epidermal gaps

immune system
• mutants exhibit an increase in mast cells with age
• IgE levels are normal in young mutants but adults show a 30-fold increase compared to wild-type mice
• 5-fold increase in serum IgG1 levels in adults
• marker analysis indicates that mutants exhibit a biphastic T-helper cell response, with a TH2 response during the acute phase of dermatitis followed by a TH1 response during the chronic phase of dermatitis
• mutants develop atopic dermatitis-like skin disease
• about 90% of mutants exhibit a uniform skin phenotype and die by P15 while mutants that survive longer than P15, exhibit the skin phenotype on the posterior region of the back skin

homeostasis/metabolism
• cutaneous edema is seen in the ears and feet
• affected skin of mutants surviving longer than P15 shows suprabasal cells with increased intracellular space, indicating development of spongiosis
• mutants exhibit an increase in epidermal water loss

hematopoietic system
• mutants exhibit an increase in mast cells with age
• IgE levels are normal in young mutants but adults show a 30-fold increase compared to wild-type mice
• 5-fold increase in serum IgG1 levels in adults
• marker analysis indicates that mutants exhibit a biphastic T-helper cell response, with a TH2 response during the acute phase of dermatitis followed by a TH1 response during the chronic phase of dermatitis

cardiovascular system
• 2.5-fold increase in the numbers of blood vessels in the skin as indicated by marker analysis

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
atopic dermatitis DOID:3310 OMIM:603165
OMIM:PS603165
J:167299





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
03/24/2020
MGI 6.15
The Jackson Laboratory